TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Sleeping Pills (Prescription Drugs) Market Report & Forecast 2022-2028

Global and United States Sleeping Pills (Prescription Drugs) Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 12 September 2022
  • Pages :108
  • Formats:
  • Report Code:SMR-7345710
OfferClick for best price

Best Price: $3480

Sleeping Pills Prescription Drugs Market Size, Share 2022


Market Analysis and Insights: Global Sleeping Pills Prescription Drugs Market

The global Sleeping Pills Prescription Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sleeping Pills Prescription Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sleeping Pills Prescription Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sleeping Pills Prescription Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sleeping Pills Prescription Drugs market.

Global Sleeping Pills Prescription Drugs Scope and Market Size

Sleeping Pills (Prescription Drugs) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Sleeping Pills (Prescription Drugs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Sleeping Pills (Prescription Drugs) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Zolpidem

Eszopiclone (Lunesta)

Ramelteon (Rozerem)

Ativan (lorazepam)

Adapin (doxepin)

Segment by Application

Hospital Pharmacy

Retail Pharmacy

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Sanofi

Abbott Laboratories

Takeda Pharmaceutical

Apotex

Aurobindo Pharma

Actellon Pharmaceuticals

Allegiant Health

Cayman Chemical

Ambitropin

Hayao

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Sleeping Pills Prescription Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Sleeping Pills Prescription Drugs, with price, sales, revenue, and global market share of Sleeping Pills Prescription Drugs from 2019 to 2022.

Chapter 3, the Sleeping Pills Prescription Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Sleeping Pills Prescription Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Sleeping Pills Prescription Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Sleeping Pills Prescription Drugs.

Chapter 13, 14, and 15, to describe Sleeping Pills Prescription Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Sleeping Pills Prescription Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Sleeping Pills (Prescription Drugs) Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 108 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Sleeping Pills (Prescription Drugs) Product Introduction
1.2 Global Sleeping Pills (Prescription Drugs) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Sleeping Pills (Prescription Drugs) Sales in US$ Million for the Year 2017-2028
1.2.2 Global Sleeping Pills (Prescription Drugs) Sales in Volume for the Year 2017-2028
1.3 United States Sleeping Pills (Prescription Drugs) Outlook 2017 VS 2022 VS 2028
1.3.1 United States Sleeping Pills (Prescription Drugs) Sales in US$ Million for the Year 2017-2028
1.3.2 United States Sleeping Pills (Prescription Drugs) Sales in Volume for the Year 2017-2028
1.4 Sleeping Pills (Prescription Drugs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Sleeping Pills (Prescription Drugs) in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Sleeping Pills (Prescription Drugs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Sleeping Pills (Prescription Drugs) Market Dynamics
1.5.1 Sleeping Pills (Prescription Drugs) Industry Trends
1.5.2 Sleeping Pills (Prescription Drugs) Market Drivers
1.5.3 Sleeping Pills (Prescription Drugs) Market Challenges
1.5.4 Sleeping Pills (Prescription Drugs) Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Sleeping Pills (Prescription Drugs) Market Segment by Type
2.1.1 Zolpidem
2.1.2 Eszopiclone (Lunesta)
2.1.3 Ramelteon (Rozerem)
2.1.4 Ativan (lorazepam)
2.1.5 Adapin (doxepin)
2.2 Global Sleeping Pills (Prescription Drugs) Market Size by Type
2.2.1 Global Sleeping Pills (Prescription Drugs) Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Sleeping Pills (Prescription Drugs) Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Sleeping Pills (Prescription Drugs) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Sleeping Pills (Prescription Drugs) Market Size by Type
2.3.1 United States Sleeping Pills (Prescription Drugs) Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Sleeping Pills (Prescription Drugs) Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Sleeping Pills (Prescription Drugs) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Sleeping Pills (Prescription Drugs) Market Segment by Application
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.2 Global Sleeping Pills (Prescription Drugs) Market Size by Application
3.2.1 Global Sleeping Pills (Prescription Drugs) Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Sleeping Pills (Prescription Drugs) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Sleeping Pills (Prescription Drugs) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Sleeping Pills (Prescription Drugs) Market Size by Application
3.3.1 United States Sleeping Pills (Prescription Drugs) Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Sleeping Pills (Prescription Drugs) Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Sleeping Pills (Prescription Drugs) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Sleeping Pills (Prescription Drugs) Competitor Landscape by Company
4.1 Global Sleeping Pills (Prescription Drugs) Market Size by Company
4.1.1 Top Global Sleeping Pills (Prescription Drugs) Manufacturers Ranked by Revenue (2021)
4.1.2 Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturer (2017-2022)
4.1.3 Global Sleeping Pills (Prescription Drugs) Sales by Manufacturer (2017-2022)
4.1.4 Global Sleeping Pills (Prescription Drugs) Price by Manufacturer (2017-2022)
4.2 Global Sleeping Pills (Prescription Drugs) Concentration Ratio (CR)
4.2.1 Sleeping Pills (Prescription Drugs) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Sleeping Pills (Prescription Drugs) in 2021
4.2.3 Global Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Sleeping Pills (Prescription Drugs) Manufacturing Base Distribution, Product Type
4.3.1 Global Sleeping Pills (Prescription Drugs) Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Sleeping Pills (Prescription Drugs) Product Type
4.3.3 Date of International Manufacturers Enter into Sleeping Pills (Prescription Drugs) Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Sleeping Pills (Prescription Drugs) Market Size by Company
4.5.1 Top Sleeping Pills (Prescription Drugs) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Sleeping Pills (Prescription Drugs) Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Sleeping Pills (Prescription Drugs) Sales by Players (2020, 2021 & 2022)
5 Global Sleeping Pills (Prescription Drugs) Market Size by Region
5.1 Global Sleeping Pills (Prescription Drugs) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Sleeping Pills (Prescription Drugs) Market Size in Volume by Region (2017-2028)
5.2.1 Global Sleeping Pills (Prescription Drugs) Sales in Volume by Region: 2017-2022
5.2.2 Global Sleeping Pills (Prescription Drugs) Sales in Volume Forecast by Region (2023-2028)
5.3 Global Sleeping Pills (Prescription Drugs) Market Size in Value by Region (2017-2028)
5.3.1 Global Sleeping Pills (Prescription Drugs) Sales in Value by Region: 2017-2022
5.3.2 Global Sleeping Pills (Prescription Drugs) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Sleeping Pills (Prescription Drugs) Market Size YoY Growth 2017-2028
6.1.2 North America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Sleeping Pills (Prescription Drugs) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Sleeping Pills (Prescription Drugs) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Sleeping Pills (Prescription Drugs) Market Size YoY Growth 2017-2028
6.3.2 Europe Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Sleeping Pills (Prescription Drugs) Market Size YoY Growth 2017-2028
6.4.2 Latin America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Corporation Information
7.1.2 Sanofi Description and Business Overview
7.1.3 Sanofi Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Sanofi Sleeping Pills (Prescription Drugs) Products Offered
7.1.5 Sanofi Recent Development
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporation Information
7.2.2 Abbott Laboratories Description and Business Overview
7.2.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Abbott Laboratories Sleeping Pills (Prescription Drugs) Products Offered
7.2.5 Abbott Laboratories Recent Development
7.3 Takeda Pharmaceutical
7.3.1 Takeda Pharmaceutical Corporation Information
7.3.2 Takeda Pharmaceutical Description and Business Overview
7.3.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Products Offered
7.3.5 Takeda Pharmaceutical Recent Development
7.4 Apotex
7.4.1 Apotex Corporation Information
7.4.2 Apotex Description and Business Overview
7.4.3 Apotex Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Apotex Sleeping Pills (Prescription Drugs) Products Offered
7.4.5 Apotex Recent Development
7.5 Aurobindo Pharma
7.5.1 Aurobindo Pharma Corporation Information
7.5.2 Aurobindo Pharma Description and Business Overview
7.5.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Products Offered
7.5.5 Aurobindo Pharma Recent Development
7.6 Actellon Pharmaceuticals
7.6.1 Actellon Pharmaceuticals Corporation Information
7.6.2 Actellon Pharmaceuticals Description and Business Overview
7.6.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Products Offered
7.6.5 Actellon Pharmaceuticals Recent Development
7.7 Allegiant Health
7.7.1 Allegiant Health Corporation Information
7.7.2 Allegiant Health Description and Business Overview
7.7.3 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Allegiant Health Sleeping Pills (Prescription Drugs) Products Offered
7.7.5 Allegiant Health Recent Development
7.8 Cayman Chemical
7.8.1 Cayman Chemical Corporation Information
7.8.2 Cayman Chemical Description and Business Overview
7.8.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Cayman Chemical Sleeping Pills (Prescription Drugs) Products Offered
7.8.5 Cayman Chemical Recent Development
7.9 Ambitropin
7.9.1 Ambitropin Corporation Information
7.9.2 Ambitropin Description and Business Overview
7.9.3 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Ambitropin Sleeping Pills (Prescription Drugs) Products Offered
7.9.5 Ambitropin Recent Development
7.10 Hayao
7.10.1 Hayao Corporation Information
7.10.2 Hayao Description and Business Overview
7.10.3 Hayao Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Hayao Sleeping Pills (Prescription Drugs) Products Offered
7.10.5 Hayao Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Sleeping Pills (Prescription Drugs) Industry Chain Analysis
8.2 Sleeping Pills (Prescription Drugs) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Sleeping Pills (Prescription Drugs) Distributors
8.3 Sleeping Pills (Prescription Drugs) Production Mode & Process
8.4 Sleeping Pills (Prescription Drugs) Sales and Marketing
8.4.1 Sleeping Pills (Prescription Drugs) Sales Channels
8.4.2 Sleeping Pills (Prescription Drugs) Distributors
8.5 Sleeping Pills (Prescription Drugs) Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Sleeping Pills (Prescription Drugs) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Sleeping Pills (Prescription Drugs) Market Trends
Table 3. Sleeping Pills (Prescription Drugs) Market Drivers
Table 4. Sleeping Pills (Prescription Drugs) Market Challenges
Table 5. Sleeping Pills (Prescription Drugs) Market Restraints
Table 6. Global Sleeping Pills (Prescription Drugs) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Sleeping Pills (Prescription Drugs) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Sleeping Pills (Prescription Drugs) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Sleeping Pills (Prescription Drugs) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Sleeping Pills (Prescription Drugs) Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Sleeping Pills (Prescription Drugs) Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Sleeping Pills (Prescription Drugs) Revenue Share by Manufacturer, 2017-2022
Table 13. Global Sleeping Pills (Prescription Drugs) Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Sleeping Pills (Prescription Drugs) Sales Share by Manufacturer, 2017-2022
Table 15. Global Sleeping Pills (Prescription Drugs) Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Sleeping Pills (Prescription Drugs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Sleeping Pills (Prescription Drugs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeping Pills (Prescription Drugs) as of 2021)
Table 18. Top Players of Sleeping Pills (Prescription Drugs) in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Sleeping Pills (Prescription Drugs) Product Type
Table 20. Date of International Manufacturers Enter into Sleeping Pills (Prescription Drugs) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Sleeping Pills (Prescription Drugs) Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Sleeping Pills (Prescription Drugs) Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Sleeping Pills (Prescription Drugs) Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Sleeping Pills (Prescription Drugs) Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Sleeping Pills (Prescription Drugs) Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Sleeping Pills (Prescription Drugs) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Sleeping Pills (Prescription Drugs) Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Sleeping Pills (Prescription Drugs) Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Sleeping Pills (Prescription Drugs) Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Sleeping Pills (Prescription Drugs) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Sleeping Pills (Prescription Drugs) Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Sleeping Pills (Prescription Drugs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Sleeping Pills (Prescription Drugs) Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Sleeping Pills (Prescription Drugs) Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Sleeping Pills (Prescription Drugs) Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Sleeping Pills (Prescription Drugs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Sleeping Pills (Prescription Drugs) Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Sleeping Pills (Prescription Drugs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Sleeping Pills (Prescription Drugs) Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Sanofi Corporation Information
Table 43. Sanofi Description and Business Overview
Table 44. Sanofi Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Sanofi Sleeping Pills (Prescription Drugs) Product
Table 46. Sanofi Recent Development
Table 47. Abbott Laboratories Corporation Information
Table 48. Abbott Laboratories Description and Business Overview
Table 49. Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Abbott Laboratories Product
Table 51. Abbott Laboratories Recent Development
Table 52. Takeda Pharmaceutical Corporation Information
Table 53. Takeda Pharmaceutical Description and Business Overview
Table 54. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Takeda Pharmaceutical Product
Table 56. Takeda Pharmaceutical Recent Development
Table 57. Apotex Corporation Information
Table 58. Apotex Description and Business Overview
Table 59. Apotex Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Apotex Product
Table 61. Apotex Recent Development
Table 62. Aurobindo Pharma Corporation Information
Table 63. Aurobindo Pharma Description and Business Overview
Table 64. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Aurobindo Pharma Product
Table 66. Aurobindo Pharma Recent Development
Table 67. Actellon Pharmaceuticals Corporation Information
Table 68. Actellon Pharmaceuticals Description and Business Overview
Table 69. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Actellon Pharmaceuticals Product
Table 71. Actellon Pharmaceuticals Recent Development
Table 72. Allegiant Health Corporation Information
Table 73. Allegiant Health Description and Business Overview
Table 74. Allegiant Health Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Allegiant Health Product
Table 76. Allegiant Health Recent Development
Table 77. Cayman Chemical Corporation Information
Table 78. Cayman Chemical Description and Business Overview
Table 79. Cayman Chemical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Cayman Chemical Product
Table 81. Cayman Chemical Recent Development
Table 82. Ambitropin Corporation Information
Table 83. Ambitropin Description and Business Overview
Table 84. Ambitropin Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Ambitropin Product
Table 86. Ambitropin Recent Development
Table 87. Hayao Corporation Information
Table 88. Hayao Description and Business Overview
Table 89. Hayao Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Hayao Product
Table 91. Hayao Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Sleeping Pills (Prescription Drugs) Customers List
Table 95. Sleeping Pills (Prescription Drugs) Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Sleeping Pills (Prescription Drugs) Product Picture
Figure 2. Global Sleeping Pills (Prescription Drugs) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Sleeping Pills (Prescription Drugs) Market Size 2017-2028 (US$ Million)
Figure 4. Global Sleeping Pills (Prescription Drugs) Sales 2017-2028 (K Units)
Figure 5. United States Sleeping Pills (Prescription Drugs) Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Sleeping Pills (Prescription Drugs) Market Size 2017-2028 (US$ Million)
Figure 7. United States Sleeping Pills (Prescription Drugs) Sales 2017-2028 (K Units)
Figure 8. United States Sleeping Pills (Prescription Drugs) Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Sleeping Pills (Prescription Drugs) Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Sleeping Pills (Prescription Drugs) Report Years Considered
Figure 11. Product Picture of Zolpidem
Figure 12. Product Picture of Eszopiclone (Lunesta)
Figure 13. Product Picture of Ramelteon (Rozerem)
Figure 14. Product Picture of Ativan (lorazepam)
Figure 15. Product Picture of Adapin (doxepin)
Figure 16. Global Sleeping Pills (Prescription Drugs) Market Share by Type in 2022 & 2028
Figure 17. Global Sleeping Pills (Prescription Drugs) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global Sleeping Pills (Prescription Drugs) Sales Market Share in Value by Type (2017-2028)
Figure 19. Global Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028) & (K Units)
Figure 20. Global Sleeping Pills (Prescription Drugs) Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global Sleeping Pills (Prescription Drugs) Price by Type (2017-2028) & (USD/Unit)
Figure 22. United States Sleeping Pills (Prescription Drugs) Market Share by Type in 2022 & 2028
Figure 23. United States Sleeping Pills (Prescription Drugs) Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States Sleeping Pills (Prescription Drugs) Sales Market Share in Value by Type (2017-2028)
Figure 25. United States Sleeping Pills (Prescription Drugs) Sales by Type (2017-2028) & (K Units)
Figure 26. United States Sleeping Pills (Prescription Drugs) Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States Sleeping Pills (Prescription Drugs) Price by Type (2017-2028) & (USD/Unit)
Figure 28. Product Picture of Hospital Pharmacy
Figure 29. Product Picture of Retail Pharmacy
Figure 30. Global Sleeping Pills (Prescription Drugs) Market Share by Application in 2022 & 2028
Figure 31. Global Sleeping Pills (Prescription Drugs) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Sleeping Pills (Prescription Drugs) Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028) & (K Units)
Figure 34. Global Sleeping Pills (Prescription Drugs) Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Sleeping Pills (Prescription Drugs) Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Sleeping Pills (Prescription Drugs) Market Share by Application in 2022 & 2028
Figure 37. United States Sleeping Pills (Prescription Drugs) Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Sleeping Pills (Prescription Drugs) Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Sleeping Pills (Prescription Drugs) Sales by Application (2017-2028) & (K Units)
Figure 40. United States Sleeping Pills (Prescription Drugs) Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Sleeping Pills (Prescription Drugs) Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Sleeping Pills (Prescription Drugs) Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Sleeping Pills (Prescription Drugs) Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Sleeping Pills (Prescription Drugs) Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 66. Latin America Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Sleeping Pills (Prescription Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Sleeping Pills (Prescription Drugs) Value Chain
Figure 76. Sleeping Pills (Prescription Drugs) Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount